Type 1 Diabetes Drugs Market Report

Global and China Type 1 Diabetes Drugs Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 02, 2022
  • PAGES：222
  • REPORT CODE：GMM1338303
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Type 1 Diabetes Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Yiling(US)

    • Burkert(DE)

    • Baiyun Mountain(JP)

    • KOSAPLUS(KR)

    • Novartis(US)

    • Ginwa(ES)

    • ASTRAZENECA(JP)

    • Insulet(US)

    • Medtronic(IT)

    • Sanofi(DE)

    • JUMCAN(SK)

    • BOEHRINGER INGELHEIM(US)

    • Bristol-Myers Squibb(US)

    • Hisun(DE)

    • Wanbang(IT)

    • Eli Lilly(UK)

    • TIANAN(IT)

    • ATI(US)

    • TANDEM(CH)

    • Takada(US)

    • Gan & Lee(US)

    • Taloph(US)

    • Novo Nordisk(US)

    • NCPC(US)

    • Dongbao(IT)

    • HUADONG MEDICINE(DE)

    • Kelun(US)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Peroral Drugs

    • Injection

    Application:

    • Hospital

    • Clinic

    • Pharmacy

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Type 1 Diabetes Drugs Industry Overview

      • 1.1.1 Type 1 Diabetes Drugs Market Scope and Market Segments

      • 1.1.2 Type 1 Diabetes Drugs Industry Characteristics

      • 1.1.3 Global and China Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Type 1 Diabetes Drugs Production Value and Growth Rate (2017-2028)

    • 1.2 Global Type 1 Diabetes Drugs Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Peroral Drugs

      • 1.2.2 Injection

    • 1.3 Global Type 1 Diabetes Drugs Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinic

      • 1.3.3 Pharmacy

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Type 1 Diabetes Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Type 1 Diabetes Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Type 1 Diabetes Drugs Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Type 1 Diabetes Drugs Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Type 1 Diabetes Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Type 1 Diabetes Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Type 1 Diabetes Drugs Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Type 1 Diabetes Drugs Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Type 1 Diabetes Drugs Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Type 1 Diabetes Drugs Industry Porter's Five Forces Model Analysis

      • 2.2.3 Type 1 Diabetes Drugs Industry PEST Analysis

    • 2.3 Type 1 Diabetes Drugs Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Type 1 Diabetes Drugs Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Type 1 Diabetes Drugs Industry

    Chapter 3 Global and China Type 1 Diabetes Drugs Market, by Manufacturer

    • 3.1 Global and China Type 1 Diabetes Drugs Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Type 1 Diabetes Drugs Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Type 1 Diabetes Drugs Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Type 1 Diabetes Drugs Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Type 1 Diabetes Drugs Market Top 3 Players

    Chapter 4 Global and China Type 1 Diabetes Drugs Market, by Type (2017-2028)

    • 4.1 Type 1 Diabetes Drugs Market Trend, by Type

    • 4.2 Global Type 1 Diabetes Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Type 1 Diabetes Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Type 1 Diabetes Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Type 1 Diabetes Drugs Price Trend, by Type (2017-2028)

    • 4.3 China Type 1 Diabetes Drugs Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Type 1 Diabetes Drugs Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Type 1 Diabetes Drugs Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Type 1 Diabetes Drugs Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Type 1 Diabetes Drugs Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Type 1 Diabetes Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Type 1 Diabetes Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Type 1 Diabetes Drugs Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Type 1 Diabetes Drugs Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Type 1 Diabetes Drugs Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Type 1 Diabetes Drugs Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Type 1 Diabetes Drugs Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Type 1 Diabetes Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Type 1 Diabetes Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Type 1 Diabetes Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Type 1 Diabetes Drugs Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Type 1 Diabetes Drugs Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Type 1 Diabetes Drugs Market Analysis

    • 7.1 North America Type 1 Diabetes Drugs Market, by Type

    • 7.2 North America Type 1 Diabetes Drugs Market, by Application

    • 7.3 North America Type 1 Diabetes Drugs Market Analysis and Forecast, by Country

      • 7.3.1 United States Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Type 1 Diabetes Drugs Market Analysis

    • 8.1 Europe Type 1 Diabetes Drugs Market, by Type

    • 8.2 Europe Type 1 Diabetes Drugs Market, by Application

    • 8.3 Europe Type 1 Diabetes Drugs Market Analysis and Forecast, by Country

      • 8.3.1 Germany Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Type 1 Diabetes Drugs Market Analysis

    • 9.1 APAC Type 1 Diabetes Drugs Market, by Type

    • 9.2 APAC Type 1 Diabetes Drugs Market, by Application

    • 9.3 APAC Type 1 Diabetes Drugs Market Analysis and Forecast, by Country

      • 9.3.1 China Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Type 1 Diabetes Drugs Market Analysis

    • 10.1 Latin America, Middle East and Africa Type 1 Diabetes Drugs Market, by Type

    • 10.2 Latin America, Middle East and Africa Type 1 Diabetes Drugs Market, by Application

    • 10.3 Latin America, Middle East and Africa Type 1 Diabetes Drugs Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Type 1 Diabetes Drugs Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Type 1 Diabetes Drugs Company Profiles

      • 11.1 Yiling(US)

        • 11.1.1 Yiling(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Yiling(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.1.3 Yiling(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Burkert(DE)

        • 11.2.1 Burkert(DE) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Burkert(DE) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.2.3 Burkert(DE) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Baiyun Mountain(JP)

        • 11.3.1 Baiyun Mountain(JP) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Baiyun Mountain(JP) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.3.3 Baiyun Mountain(JP) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 KOSAPLUS(KR)

        • 11.4.1 KOSAPLUS(KR) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 KOSAPLUS(KR) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.4.3 KOSAPLUS(KR) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Novartis(US)

        • 11.5.1 Novartis(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Novartis(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.5.3 Novartis(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Ginwa(ES)

        • 11.6.1 Ginwa(ES) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Ginwa(ES) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.6.3 Ginwa(ES) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 ASTRAZENECA(JP)

        • 11.7.1 ASTRAZENECA(JP) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 ASTRAZENECA(JP) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.7.3 ASTRAZENECA(JP) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Insulet(US)

        • 11.8.1 Insulet(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Insulet(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.8.3 Insulet(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Medtronic(IT)

        • 11.9.1 Medtronic(IT) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Medtronic(IT) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.9.3 Medtronic(IT) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Sanofi(DE)

        • 11.10.1 Sanofi(DE) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Sanofi(DE) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.10.3 Sanofi(DE) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 JUMCAN(SK)

        • 11.11.1 JUMCAN(SK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 JUMCAN(SK) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.11.3 JUMCAN(SK) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 BOEHRINGER INGELHEIM(US)

        • 11.12.1 BOEHRINGER INGELHEIM(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 BOEHRINGER INGELHEIM(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.12.3 BOEHRINGER INGELHEIM(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Bristol-Myers Squibb(US)

        • 11.13.1 Bristol-Myers Squibb(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Bristol-Myers Squibb(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.13.3 Bristol-Myers Squibb(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Hisun(DE)

        • 11.14.1 Hisun(DE) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Hisun(DE) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.14.3 Hisun(DE) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Wanbang(IT)

        • 11.15.1 Wanbang(IT) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Wanbang(IT) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.15.3 Wanbang(IT) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Eli Lilly(UK)

        • 11.16.1 Eli Lilly(UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Eli Lilly(UK) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.16.3 Eli Lilly(UK) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 TIANAN(IT)

        • 11.17.1 TIANAN(IT) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 TIANAN(IT) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.17.3 TIANAN(IT) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 ATI(US)

        • 11.18.1 ATI(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 ATI(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.18.3 ATI(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.19 TANDEM(CH)

        • 11.19.1 TANDEM(CH) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.19.2 TANDEM(CH) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.19.3 TANDEM(CH) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.20 Takada(US)

        • 11.20.1 Takada(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.20.2 Takada(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.20.3 Takada(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.21 Gan & Lee(US)

        • 11.21.1 Gan & Lee(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.21.2 Gan & Lee(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.21.3 Gan & Lee(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.22 Taloph(US)

        • 11.22.1 Taloph(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.22.2 Taloph(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.22.3 Taloph(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.23 Novo Nordisk(US)

        • 11.23.1 Novo Nordisk(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.23.2 Novo Nordisk(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.23.3 Novo Nordisk(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.24 NCPC(US)

        • 11.24.1 NCPC(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.24.2 NCPC(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.24.3 NCPC(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.25 Dongbao(IT)

        • 11.25.1 Dongbao(IT) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.25.2 Dongbao(IT) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.25.3 Dongbao(IT) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.26 HUADONG MEDICINE(DE)

        • 11.26.1 HUADONG MEDICINE(DE) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.26.2 HUADONG MEDICINE(DE) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.26.3 HUADONG MEDICINE(DE) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.27 Kelun(US)

        • 11.27.1 Kelun(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.27.2 Kelun(US) Type 1 Diabetes Drugs Product Profiles, Application and Specification

        • 11.27.3 Kelun(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Type 1 Diabetes Drugs Industry Investment Prospect and Risk Assessment

    • 12.1 Type 1 Diabetes Drugs Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Type 1 Diabetes Drugs Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Global Type 1 Diabetes Drugs Production Value and Growth Rate (2017-2028)

    • Figure China Type 1 Diabetes Drugs Production Value and Growth Rate (2017-2028)

    • Figure Global Type 1 Diabetes Drugs Market Size and Growth Rate of Peroral Drugs (2017-2028)

    • Figure Global Type 1 Diabetes Drugs Market Size and Growth Rate of Injection (2017-2028)

    • Figure Global Type 1 Diabetes Drugs Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Type 1 Diabetes Drugs Market Size and Growth Rate of Clinic (2017-2028)

    • Figure Global Type 1 Diabetes Drugs Market Size and Growth Rate of Pharmacy (2017-2028)

    • Figure North America Type 1 Diabetes Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Type 1 Diabetes Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Type 1 Diabetes Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Type 1 Diabetes Drugs Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Type 1 Diabetes Drugs Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Type 1 Diabetes Drugs Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Type 1 Diabetes Drugs Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Type 1 Diabetes Drugs Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Type 1 Diabetes Drugs Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Type 1 Diabetes Drugs Market Share, by Manufacturer in 2021

    • Figure Global and China Type 1 Diabetes Drugs Market Share, by Manufacturer in 2022

    • Table Global Type 1 Diabetes Drugs Sales Volume, by Type (2017-2028)

    • Table Global Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Global Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Table Global Type 1 Diabetes Drugs Sales Value, by Type (2017-2028)

    • Table Global Type 1 Diabetes Drugs Sales Value Share, by Type (2017-2028)

    • Figure Global Type 1 Diabetes Drugs Price Trend, by Type (2017-2028)

    • Table China Type 1 Diabetes Drugs Sales Volume, by Type (2017-2028)

    • Table China Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Figure China Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Table China Type 1 Diabetes Drugs Sales Value, by Type (2017-2028)

    • Table China Type 1 Diabetes Drugs Sales Value Share, by Type (2017-2028)

    • Figure China Type 1 Diabetes Drugs Price Trend, by Type (2017-2028)

    • Table Global Type 1 Diabetes Drugs Sales Volume, by Application (2017-2028)

    • Table Global Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Global Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Table Global Type 1 Diabetes Drugs Sales Value, by Application (2017-2028)

    • Table Global Type 1 Diabetes Drugs Sales Value Share, by Application (2017-2028)

    • Figure Global Type 1 Diabetes Drugs Sales Value Share, by Application (2017-2028)

    • Table China Type 1 Diabetes Drugs Sales Volume, by Application (2017-2028)

    • Table China Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Table China Type 1 Diabetes Drugs Sales Value, by Application (2017-2028)

    • Table China Type 1 Diabetes Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Type 1 Diabetes Drugs Sales Value Share, by Application (2017-2028)

    • Figure China Type 1 Diabetes Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure North America Type 1 Diabetes Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Type 1 Diabetes Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Type 1 Diabetes Drugs Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Type 1 Diabetes Drugs Production, Import, Consumption and Export (2017-2022)

    • Table North America Type 1 Diabetes Drugs Sales Volume, by Type (2017-2028)

    • Table North America Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Figure North America Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Table North America Type 1 Diabetes Drugs Sales Volume, by Application (2017-2028)

    • Table North America Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Figure North America Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Figure United States Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure United States Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Canada Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Table Europe Type 1 Diabetes Drugs Sales Volume, by Type (2017-2028)

    • Table Europe Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Europe Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Table Europe Type 1 Diabetes Drugs Sales Volume, by Application (2017-2028)

    • Table Europe Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Europe Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Germany Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure UK Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure UK Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure France Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure France Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Italy Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Spain Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Poland Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Russia Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Table APAC Type 1 Diabetes Drugs Sales Volume, by Type (2017-2028)

    • Table APAC Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Figure APAC Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Table APAC Type 1 Diabetes Drugs Sales Volume, by Application (2017-2028)

    • Table APAC Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Figure APAC Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Figure China Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure China Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Japan Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure India Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure India Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Type 1 Diabetes Drugs Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Type 1 Diabetes Drugs Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Type 1 Diabetes Drugs Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Type 1 Diabetes Drugs Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Type 1 Diabetes Drugs Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Type 1 Diabetes Drugs Sales Value and Growth Rate (2017-2028)

    • Table Yiling(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Yiling(US) Product Profiles, Application and Specification

    • Table Yiling(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Burkert(DE) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Burkert(DE) Product Profiles, Application and Specification

    • Table Burkert(DE) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Baiyun Mountain(JP) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Baiyun Mountain(JP) Product Profiles, Application and Specification

    • Table Baiyun Mountain(JP) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table KOSAPLUS(KR) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table KOSAPLUS(KR) Product Profiles, Application and Specification

    • Table KOSAPLUS(KR) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis(US) Product Profiles, Application and Specification

    • Table Novartis(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Ginwa(ES) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Ginwa(ES) Product Profiles, Application and Specification

    • Table Ginwa(ES) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ASTRAZENECA(JP) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ASTRAZENECA(JP) Product Profiles, Application and Specification

    • Table ASTRAZENECA(JP) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Insulet(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Insulet(US) Product Profiles, Application and Specification

    • Table Insulet(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Medtronic(IT) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Medtronic(IT) Product Profiles, Application and Specification

    • Table Medtronic(IT) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sanofi(DE) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sanofi(DE) Product Profiles, Application and Specification

    • Table Sanofi(DE) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table JUMCAN(SK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table JUMCAN(SK) Product Profiles, Application and Specification

    • Table JUMCAN(SK) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table BOEHRINGER INGELHEIM(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table BOEHRINGER INGELHEIM(US) Product Profiles, Application and Specification

    • Table BOEHRINGER INGELHEIM(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bristol-Myers Squibb(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bristol-Myers Squibb(US) Product Profiles, Application and Specification

    • Table Bristol-Myers Squibb(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hisun(DE) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hisun(DE) Product Profiles, Application and Specification

    • Table Hisun(DE) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Wanbang(IT) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Wanbang(IT) Product Profiles, Application and Specification

    • Table Wanbang(IT) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Eli Lilly(UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Eli Lilly(UK) Product Profiles, Application and Specification

    • Table Eli Lilly(UK) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table TIANAN(IT) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table TIANAN(IT) Product Profiles, Application and Specification

    • Table TIANAN(IT) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table ATI(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table ATI(US) Product Profiles, Application and Specification

    • Table ATI(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table TANDEM(CH) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table TANDEM(CH) Product Profiles, Application and Specification

    • Table TANDEM(CH) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Takada(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Takada(US) Product Profiles, Application and Specification

    • Table Takada(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Gan & Lee(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Gan & Lee(US) Product Profiles, Application and Specification

    • Table Gan & Lee(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Taloph(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Taloph(US) Product Profiles, Application and Specification

    • Table Taloph(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novo Nordisk(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novo Nordisk(US) Product Profiles, Application and Specification

    • Table Novo Nordisk(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table NCPC(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table NCPC(US) Product Profiles, Application and Specification

    • Table NCPC(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dongbao(IT) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dongbao(IT) Product Profiles, Application and Specification

    • Table Dongbao(IT) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table HUADONG MEDICINE(DE) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table HUADONG MEDICINE(DE) Product Profiles, Application and Specification

    • Table HUADONG MEDICINE(DE) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Kelun(US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Kelun(US) Product Profiles, Application and Specification

    • Table Kelun(US) Type 1 Diabetes Drugs Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US